Previously, elevated levels of moesin and ezrin were found in TSC-related cranial lesions, which co-localized with Tuberin and Hamartin in the glial cell population of the lesions, suggesting that increased moesin and ezrin may be a compensatory response following TSC gene mutation [28]. This evidence concerns the gene TSC2 and tuberous sclerosis.